Clinical Trial Update: Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD) [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating oseltamivir (Tamiflu) in critically ill patients on extracorporeal membrane oxygenation (ECMO) or continuous venovenous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure

Drugs mentioned

• Tamiflu (oseltamivir)

Snippet

Sponsor: University of Michigan | Conditions: Critically Ill Renal Failure Requiring CVVHD and Oseltamivir, Critically Ill Requiring ECMO and Oseltamivir | Phase 4 | Status: COMPLETED | Results posted: 2012-08-21